Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-ketamine and sufentanil for post-cesarean analgesia
NCT05299866Phase 4Unknown
- Sponsor
- Lingdong Biotech
- Start
- Apr 2022
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of esketamine in postoperative pain, sponsored by Lingdong Biotech. Status: unknown.
02
Drugs
esketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05299866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05299866.